Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
Response to Farooki and Schneider
- Samantha L. Bowker, MSC1,
- Sumit R. Majumdar, MD, MPH12,
- Paul Veugelers, PHD3 and
- Jeffrey A. Johnson, PHD13
- 1Institute of Health Economics, Edmonton, Alberta, Canada
- 2Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 3Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
- Address correspondence to Dr. Jeffrey A. Johnson, #1200, 10405 Jasper Ave., Edmonton, Alberta, T5J 3N4, Canada. E-mail: jeff.johnson{at}ualberta.ca
Article Information
vol. 29 no. 8 1990-1991
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print July 27, 2006.
Copyright & Usage
DIABETES CARE
Author Information
- Samantha L. Bowker, MSC1,
- Sumit R. Majumdar, MD, MPH12,
- Paul Veugelers, PHD3 and
- Jeffrey A. Johnson, PHD13
- 1Institute of Health Economics, Edmonton, Alberta, Canada
- 2Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 3Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
- Address correspondence to Dr. Jeffrey A. Johnson, #1200, 10405 Jasper Ave., Edmonton, Alberta, T5J 3N4, Canada. E-mail: jeff.johnson{at}ualberta.ca
Statistics from Altmetric.com
Article usage
In this Issue
August 2006, 29(8)
Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
